Pathology liability insurance for anatomic, surgical, cytology, and molecular pathology.

Pathology liability insurance is the specialty professional liability program for anatomic pathology, surgical pathology, cytology, and molecular pathology operators. It covers diagnostic accuracy claims (the highest claim severity category in lab insurance) - missed cancer diagnoses, false positives, sample mix-ups, transcription errors, and subspecialty interpretation failures. Coverage typically pairs entity-level pathology liability insurance (covering the lab business) with individual pathologist malpractice insurance (covering each physician for their professional services).

Generic medical malpractice forms exclude or sublimit lab and diagnostic accuracy claims - the forms were written for direct patient-care professional services. Pathology liability is specifically structured for pathologists and pathology labs: it includes explicit diagnostic accuracy scope, subspecialty endorsements (molecular pathology, immunohistochemistry, FISH, digital pathology AI/ML), sample-switching and mislabeling coverage with appropriate sublimits, and coordination with the lab entity's professional liability program.

Pathologist malpractice insurance typically runs $4,000-$15,000 per pathologist per year for $1M/$3M claims-made coverage, scaling with subspecialty (cytopathology and surgical oncology pathology run higher), state jurisdiction (Texas favorable, NY/IL/CA materially higher), and prior claims history. Anatomic pathology and surgical pathology carry materially higher premiums than clinical pathology. Pathology groups typically purchase entity-level pathology liability separately at $5K-$30K annually depending on lab type and revenue.

Yes - the standard structure is individual pathologist malpractice for each physician (covering their personal professional services) plus entity-level pathology liability for the pathology group / lab business (covering the entity's lab operations, sample handling, reporting infrastructure). The two coordinate but are not substitutes. A pathology group operating only on individual malpractice has uninsured entity-level exposure for diagnostic accuracy claims that target the lab as an institution.

Pathology liability insurance is structured to coordinate with the underlying clinical lab insurance program. The lab insurance covers cyber, property, and CGL; the pathology liability covers the diagnostic accuracy claim layer. For mid-market anatomic pathology operations, the recommended structure is: $5M-$10M pathology liability / diagnostic accuracy E&O on the lab entity, $1M/$3M individual malpractice on each pathologist, $5M-$15M cyber sized to specimen volume and PHI sensitivity, plus the standard CGL / property / workers comp stack.

Molecular pathology (NGS, PCR-based, oncology genomics) requires LDT regulatory uncertainty endorsement following the March 2025 FDA enforcement posture changes. Cytopathology requires explicit fine-needle aspiration and ThinPrep scope. Surgical pathology requires frozen-section and intraoperative consultation scope. Digital pathology requires AI/ML algorithm liability scope where the lab uses computational tools. Hematopathology and dermatopathology each have subspecialty-specific underwriting considerations. The carrier panel actively underwriting these is a narrow specialty set, not the broader admitted medical malpractice market.